BioCentury
ARTICLE | Company News

UCB management update

January 9, 2012 8:00 AM UTC

UCB Group (Euronext:UCB), Brussels, Belgium Business: Neurology, Autoimmune, Inflammation Hired: Mark Bodmer as VP, head of immunology of UCB NewMedicines, formerly SVP of immunoinflammation, medicine...